Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade

Life Sciences
Ivana VanêckováJ Zicha

Abstract

Chronic endothelin receptor A (ETA) blockade lowered blood pressure (BP) by decreasing angiotensin-dependent vasoconstriction and attenuating calcium influx. We tested whether the addition of ETA blockade to renin-angiotensin system (RAS) blockade would have further effects on the principal vasoactive systems contributing to BP maintenance in Ren-2 transgenic rats (TGR). Four-week-old TGR rats were fed with normal-salt diet and given either different renin-angiotensin system (RAS) blockers [angiotensin receptor blocker losartan, angiotensin converting enzyme inhibitor captopril, direct renin inhibitor aliskiren], or ETA blocker (atrasentan) alone, or a combination of atrasentan with RAS blockers for 4weeks. At the end of the study, basal BP and acute BP responses to sequential blockade of renin-angiotensin (RAS), sympathetic nervous (SNS), and nitric oxide (NO) systems were determined in conscious rats. Thereafter, BP responses to acute inhibition of nifedipine-sensitive calcium influx through voltage-dependent calcium channels (L-VDCC) were measured. All RAS blockers similarly decreased BP to normotension, their effects being mediated through substantially attenuated RAS-dependent and moderately decreased SNS-dependent vasocon...Continue Reading

References

Aug 1, 1990·Journal of Molecular and Cellular Cardiology·H KawaguchiH Yasuda
Mar 24, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Josef ZichaJaroslav Kunes
May 8, 2008·American Journal of Physiology. Endocrinology and Metabolism·Adam Whaley-ConnellJames R Sowers
Jun 6, 2008·The New England Journal of Medicine·Hans-Henrik ParvingUNKNOWN AVOID Study Investigators
Aug 14, 2009·American Journal of Physiology. Renal Physiology·Elena GagliardiniAriela Benigni
Feb 20, 2010·Journal of the American Society of Nephrology : JASN·Johannes F E MannUNKNOWN ASCEND Study Group
Mar 6, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·David L Feldman
Feb 26, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Frederik PerssonHans-Henrik Parving
Apr 7, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Laima SiddiqiPeter J Blankestijn
Jan 21, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Bing S HuangFrans H H Leenen
Nov 17, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yongfei ChenFeng Yu
Dec 12, 2012·Cardiovascular Drugs and Therapy·Thomas G von Lueder, Henry Krum
Feb 6, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Graziano Riccioni
Sep 23, 2014·Life Sciences·Matthias Barton
Mar 6, 2015·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Renata V TiradentesSonia A Gouvea

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.